Complete Heart Block Clinical Trial
Official title:
Assessing the Impact of Aminophylline in the Reversal of Complete Heart Block Secondary to Inferior Wall MI in Atropine Resistant Patients: An Open Label Non-randomized Clinical Trial
In this study we will evaluate the rate of reversal of complete heart block with aminophylline in atropine resistant patients with inferior wall myocardial infarction (MI)
Administration of Aminophylline can result in reversal of complete heart block in a significant number of atropine resistant patients with inferior wall MI. Hence, in this study our primary aim is to evaluate the rate of reversal of complete heart block with aminophylline in atropine resistant patients with inferior wall MI. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04245345 -
Accelerometer Sensing for Micra AV Study
|
N/A | |
| Completed |
NCT00374608 -
Exercise in Chronically Paced Children
|
N/A | |
| Recruiting |
NCT05541679 -
Comparison of Left Bundle Branch Area Versus Right Ventricular Septal Pacing in Patients With High-degree Conduction Disease After Transcatheter Aortic Valve Replacement (Left Bundle BRAVE)
|
N/A | |
| Completed |
NCT04931693 -
PECs Block for Pacemaker Insertion in Children
|
Phase 4 | |
| Completed |
NCT02809131 -
Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.
|
Phase 3 |